MedPath
HSA Approval

MOXICLAV 1G TABLETS

SIN13547P

MOXICLAV 1G TABLETS

MOXICLAV 1G TABLETS

September 3, 2008

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE SINGAPORE PTE. LTD.

Regulatory Information

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE SINGAPORE PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01CR02

amoxicillin and beta-lactamase inhibitor

Manufacturer Information

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE LTD (FACTORY B – ORAL FACILITY)

Active Ingredients

AMOXICILLIN TRIHYDRATE EQV. AMOXICILLIN BASE

875.0 MG

Amoxicillin

CLAVULANATE POTASSIUM + MICROCRYSTALLINE CELLULOSE EQV. TO CLAVULANIC ACID

125.0 MG

Clavulanic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MOXICLAV 1G TABLETS - HSA Approval | MedPath